Instil Bio, Inc. Common Stock

TILNASDAQUSD
8.07 USD
0.07 (0.86%)AT CLOSE (11:59 AM EDT)
8.08
0.01 (0.06%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
8.08
0.01 (0.06%)
🔴Market: CLOSED
Open?$8.14
High?$8.14
Low?$8.01
Prev. Close?$8.14
Volume?6.3K
Avg. Volume?27.8K
VWAP?$8.08
Rel. Volume?0.23x
Bid / Ask
Bid?$6.96 × 100
Ask?$9.19 × 100
Spread?$2.23
Midpoint?$8.08
Valuation & Ratios
Market Cap?54.7M
Shares Out?6.8M
Float?4.1M
Float %?61.1%
P/E Ratio?N/A
P/B Ratio?0.49
EPS?-$6.99
Dividend?0.00%
Ex-Dividend?N/A

TIL is currently priced at $8.07. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. TIL is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
Employees
17
Market Cap
54.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-03-19
Address
3963 MAPLE AVENUE
DALLAS, TX 75219
Phone: (972) 499-3350
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-2/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
68
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.61Distress
Confidence?41%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?5.58%Elevated
Short Interest?231.4K
Days to Cover?7.7
Free Float4.1M
Avg Daily Volume30.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?39.84Strong
Quick Ratio?39.84Strong
Cash Ratio?1.06Strong
Debt/Equity?0.77Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.49CHEAP
P/S?
Peers
100
S&P
3
24.41HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.3CHEAP
EV/Sales?
Peers
100
S&P
3
60.08HIGH
Returns & Efficiency
ROE?
S&P
3
-42.8%WEAK
ROA?
S&P
3
-23.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$134.7M
Fundamentals ratios updated end of day